Physician profile
David A Hunter
NPI 1124311311
$8,703.51
in general payments reported to CMS, 2019-2025
23 companies · $836 in 2025
The $836 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,573 · 2020: $446 · 2021: $620 · 2022: $1,075 · 2023: $626 · 2024: $527 · 2025: $836.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,956 · Honoraria: $32.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,955.83 |
| Honoraria | $32.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $2,819.23 | 2019-2024 | Veritas Vision System, Tecnis Iol, Tecnis Simplicity |
| Glaukos Corporation | $1,680.64 | 2019-2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Sun Pharmaceutical Industries INC. | $977.89 | 2019-2025 | Cequa |
| Alcon Vision LLC | $882.79 | 2019-2025 | Clareon, Hydrus Microstent, Rocklatan |
| Kala Pharmaceuticals, INC. | $563.09 | 2019-2021 | |
| Abbvie INC. | $477.67 | 2022-2025 | |
| Biotissue Holdings INC. | $289.79 | 2022-2025 | |
| Allergan, INC. | $258.04 | 2020-2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $145.10 | 2019-2021 | |
| Rxsight INC | $126.10 | 2022-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Bausch & Lomb Americas INC. | $120.22 | 2022-2025 | Xiidra, Miebo, Envista Mx60 Iol |
| Novartis Pharmaceuticals Corporation | $64.98 | 2019-2023 | |
| Tarsus Pharmaceuticals, INC. | $54.60 | 2024-2025 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $47.31 | 2021-2022 | |
| Sight Sciences, INC. | $33.44 | 2023-2024 | Omni Surgical System |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Staar Surgical Company | $31.95 | 2019 | |
| Dompe US, INC. | $26.20 | 2025 | Oxervate |
| Thea Pharma INC. | $22.14 | 2025 | Iyuzeh |
| Eyevance Pharmaceuticals LLC | $19.77 | 2022 | |
| Ocular Therapeutix, INC. | $16.62 | 2020 | |
| New World Medical,INC. | $16.60 | 2021 | |
| Lensar, INC. | $16.02 | 2019 | |
| Rayner Intraocular Lenses Limited | $13.32 | 2023 | Rayone Aspheric, Omidria, Rayone Emv |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.